JP2021515004A5 - - Google Patents

Info

Publication number
JP2021515004A5
JP2021515004A5 JP2020545526A JP2020545526A JP2021515004A5 JP 2021515004 A5 JP2021515004 A5 JP 2021515004A5 JP 2020545526 A JP2020545526 A JP 2020545526A JP 2020545526 A JP2020545526 A JP 2020545526A JP 2021515004 A5 JP2021515004 A5 JP 2021515004A5
Authority
JP
Japan
Prior art keywords
propanamide
oxy
dimethyl
pyridine
methylpiperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020545526A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515004A (ja
JP7297776B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/020086 external-priority patent/WO2019169153A1/en
Publication of JP2021515004A publication Critical patent/JP2021515004A/ja
Publication of JP2021515004A5 publication Critical patent/JP2021515004A5/ja
Priority to JP2023098091A priority Critical patent/JP2023134444A/ja
Application granted granted Critical
Publication of JP7297776B2 publication Critical patent/JP7297776B2/ja
Priority to JP2025016827A priority patent/JP2025084759A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020545526A 2018-03-01 2019-02-28 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート Active JP7297776B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023098091A JP2023134444A (ja) 2018-03-01 2023-06-14 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート
JP2025016827A JP2025084759A (ja) 2018-03-01 2025-02-04 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862637295P 2018-03-01 2018-03-01
US62/637,295 2018-03-01
PCT/US2019/020086 WO2019169153A1 (en) 2018-03-01 2019-02-28 Piperidinyl-3-(aryloxy)propanamides and propanoates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023098091A Division JP2023134444A (ja) 2018-03-01 2023-06-14 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート

Publications (3)

Publication Number Publication Date
JP2021515004A JP2021515004A (ja) 2021-06-17
JP2021515004A5 true JP2021515004A5 (enExample) 2022-03-10
JP7297776B2 JP7297776B2 (ja) 2023-06-26

Family

ID=65763866

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020545526A Active JP7297776B2 (ja) 2018-03-01 2019-02-28 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート
JP2023098091A Pending JP2023134444A (ja) 2018-03-01 2023-06-14 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート
JP2025016827A Pending JP2025084759A (ja) 2018-03-01 2025-02-04 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023098091A Pending JP2023134444A (ja) 2018-03-01 2023-06-14 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート
JP2025016827A Pending JP2025084759A (ja) 2018-03-01 2025-02-04 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート

Country Status (22)

Country Link
US (3) US11045457B2 (enExample)
EP (1) EP3759094A1 (enExample)
JP (3) JP7297776B2 (enExample)
KR (2) KR102822276B1 (enExample)
CN (1) CN112236423B (enExample)
AR (1) AR114421A1 (enExample)
AU (1) AU2019228568B2 (enExample)
BR (1) BR112020017644A2 (enExample)
CA (1) CA3092450A1 (enExample)
CL (1) CL2020002257A1 (enExample)
EA (1) EA202092054A1 (enExample)
EC (1) ECSP20062464A (enExample)
IL (1) IL276998B2 (enExample)
MX (1) MX2020009062A (enExample)
MY (1) MY206763A (enExample)
PE (1) PE20211313A1 (enExample)
PH (1) PH12020551359A1 (enExample)
SG (1) SG11202008398XA (enExample)
TW (1) TWI834637B (enExample)
UA (1) UA126829C2 (enExample)
WO (1) WO2019169153A1 (enExample)
ZA (1) ZA202005438B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI834637B (zh) * 2018-03-01 2024-03-11 日商武田藥品工業有限公司 六氫吡啶基-3-(芳氧基)丙醯胺及丙酸酯
GB201901559D0 (en) * 2019-02-05 2019-03-27 Syngenta Crop Protection Ag Herbicidal compositions
WO2021143680A1 (zh) 2020-01-16 2021-07-22 浙江海正药业股份有限公司 杂芳基类衍生物及其制备方法和用途
AR121682A1 (es) * 2020-03-31 2022-06-29 Takeda Pharmaceuticals Co Derivados de n-(heterociclil y heterociclilalquil)-3-bencilpiridin-2-amina como agonistas de sstr4
AR121683A1 (es) * 2020-03-31 2022-06-29 Takeda Pharmaceuticals Co Derivados de n-heteroarilalquil-2-(heterociclil y heterociclilmetil)acetamida como agonistas de sstr4
WO2021233428A1 (zh) * 2020-05-21 2021-11-25 广州费米子科技有限责任公司 含氮饱和杂环化合物及其制备方法、药物组合物和应用
IL300893A (en) * 2020-08-24 2023-04-01 Hua Medicine Shanghai Ltd Preparation of modified acrylate compounds
EP4304586A4 (en) 2021-03-10 2025-04-02 Jnana Therapeutics Inc. SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION
CN115477640A (zh) * 2021-05-31 2022-12-16 由理生物医药（上海）有限公司 作为parp7抑制剂的哒嗪酮类化合物
KR20240169050A (ko) * 2022-03-30 2024-12-02 다케다 야쿠힌 고교 가부시키가이샤 N-(피롤리딘-3-일 또는 피페리딘-4-일)아세트아마이드 유도체
WO2025247982A1 (en) 2024-05-29 2025-12-04 Grünenthal GmbH Piperazines which act as sstr4 modulators

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
SE9902987D0 (sv) * 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CN1960970A (zh) * 2004-05-28 2007-05-09 田边制药株式会社 作为cb1受体的拮抗剂的吡咯烷衍生物
TW200602314A (en) 2004-05-28 2006-01-16 Tanabe Seiyaku Co A novel pyrrolidine compound and a process for preparing the same
CN101163676A (zh) 2005-02-23 2008-04-16 普雷萨药品公司 用于治疗运动障碍及其它cns适应症的多巴胺转运蛋白抑制剂
ES2330788T3 (es) 2005-06-02 2009-12-15 F. Hoffmann-La Roche Ag Derivados de piperidin-4-il-amida y su uso como antagonistas del subtipo 5 del receptor sst.
JP4943826B2 (ja) * 2005-11-25 2012-05-30 田辺三菱製薬株式会社 医薬組成物
JP5736098B2 (ja) * 2007-08-21 2015-06-17 アッヴィ・インコーポレイテッド 中枢神経系障害を治療するための医薬組成物
JP5509104B2 (ja) * 2008-03-14 2014-06-04 エグゼリクシス， インコーポレイテッド １１β−ＨＳＤ１モジュレータとしてのアザビシクロ［３．２．１］オクチル誘導体
WO2010059922A1 (en) 2008-11-21 2010-05-27 Ligand Pharmaceuticals Incorporated Pyrrolidine carboxamide compounds
BR112012008147A2 (pt) 2009-09-04 2016-03-01 Novartis Ag compostos heteroarílicos como inibidores da quinase
US9371282B2 (en) 2013-05-17 2016-06-21 Centrexion Therapeutics Corporation Somatostatin receptor subtype 4 (SSTR4) agonists
EP3045448A4 (en) * 2013-09-12 2017-01-25 Sumitomo Chemical Company Limited Nitrogen-containing saturated heterocyclic compound
BR112017009595A2 (pt) * 2014-11-14 2017-12-19 Boehringer Ingelheim Int morfolina e 1,4-oxazepano amidas como agonistas do subtipo de receptor de somatostatina 4 (sstr4)
US9957267B2 (en) 2015-07-01 2018-05-01 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
TWI834637B (zh) * 2018-03-01 2024-03-11 日商武田藥品工業有限公司 六氫吡啶基-3-(芳氧基)丙醯胺及丙酸酯

Similar Documents

Publication Publication Date Title
JP2021515004A5 (enExample)
IL276998B1 (en) Piperidinyl-3-(aryloxy)propanamides and propanoates
RU2455288C2 (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JP2021515033A5 (enExample)
RU2356893C2 (ru) Ингибиторы фосфодиэстеразы 4
CA2601508A1 (en) Cyclopropanecarboxamide derivatives
RU2012129737A (ru) Замещенные бензамидные производные
JP2023531709A5 (enExample)
JP2013523636A5 (enExample)
HRP20120656T1 (hr) Derivati indazolil amida za liječenje poremećaja posredovanih glukokortikoidnim receptorom
HRP20170638T1 (hr) MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI
JP2013512899A5 (enExample)
JP2014505037A5 (enExample)
JP2020506171A5 (enExample)
JP2017511794A5 (enExample)
RU2010129541A (ru) Карбоксил- или гидроксилзамещенные производные бензимидазола
JP2014500330A5 (enExample)
JP2022548568A5 (enExample)
RU2017116197A (ru) 2-амино-3,5-дифтор-3,6-диметил-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 для лечения болезни альцгеймера
JP2022536773A5 (enExample)
JP2024518792A5 (enExample)
JP2020527175A5 (enExample)
JP2004529931A5 (enExample)
JP2023531495A5 (enExample)
JP2012518634A5 (enExample)